HMG-CoA Reductase Inhibitor [EPC]

328378 reported adverse events

Drugs of this class: SIMVASTATIN LOVASTATIN EZETIMIBE AND SIMVASTATIN ATORVASTATIN CALCIUM PITAVASTATIN MAGNESIUM ROSUVASTATIN

These side effects are most commonly reported by patients taking drugs of the HMG-CoA Reductase Inhibitor [EPC] class:

# Side effect Count
0 FATIGUE 17560
1 NAUSEA 16493
2 DRUG INEFFECTIVE 16412
3 DYSPNOEA 15859
4 DIARRHOEA 14740
5 DIZZINESS 13892
6 ASTHENIA 11905
7 PAIN 11760
8 FALL 11473
9 HEADACHE 11042
See all common reactions for HMG-CoA Reductase Inhibitor [EPC]

Drugs of the HMG-CoA Reductase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IMMUNE-MEDIATED NECROTISING MYOPATHY 251 0.4547
1 IMMUNE-MEDIATED MYOSITIS 299 0.3833
2 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 241 0.2648
3 MYOPATHY 1681 0.2570
4 HYPERPARATHYROIDISM SECONDARY 541 0.2549
5 NEPHROGENIC ANAEMIA 958 0.2306
6 RHABDOMYOLYSIS 7049 0.2233
7 REBOUND ACID HYPERSECRETION 517 0.1787
8 SEDATION COMPLICATION 196 0.1569
9 POLYMYOSITIS 206 0.1483
See all enriched reactions for HMG-CoA Reductase Inhibitor [EPC]